STERIS (STE) reported fiscal Q3 adjusted net income late Wednesday of $2.53 per diluted share, up from $2.32 a year earlier.

Analysts polled by FactSet expected $2.53.

Revenue for the three months ended Dec. 31 rose to $1.50 billion from $1.37 billion a year earlier.

Analysts polled by FactSet expected $1.48 billion.

STERIS maintained its full-year 2026 guidance to adjusted EPS of $10.15 to $10.30.

Analysts surveyed by FactSet expect EPS of $10.22.